Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant573 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,386 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03084081 | An Innovative Treatment for Cervical Precancer (UH3)(UH3) | completed | N/A | 1,132 | The Cleveland ClinicOTHER | 3 | Apr 6, 2025 | clinicaltrials |
| NCT04925284 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | completed | Phase 1 | 269 | ExelixisINDUSTRY | 9 | Apr 4, 2025 | clinicaltrials |
| NCT06137950 |
| Interferon Alpha Therapy for Cervical CINI and HPV Infection |
| completed |
| Phase 1 |
| 60 |
| Mongolian National University of Medical SciencesOTHER |
| 1 |
| Apr 3, 2025 |
| clinicaltrials |
| NCT03894618 | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 49 | Shattuck Labs, Inc.INDUSTRY | 4 | Apr 2, 2025 | clinicaltrials |
| NCT03749707 | HPV in Sentinel Lymph Nodes of Cervical Cancer Patients | completed | N/A | 127 | University of AarhusOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06897306 | Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study | completed | — | 317 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT02684227 | Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer | completed | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT04499521 | A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer | completed | N/A | 21 | University of VirginiaOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT04995809 | Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome(EPRIMM) | completed | — | 18 | The Christie NHS Foundation TrustOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06149598 | Coughing at Time of Cervical Biopsy | completed | N/A | 30 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT04380805 | A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer | completed | Phase 2 | 30 | AkesoINDUSTRY | 3 | Feb 28, 2025 | clinicaltrials |
| NCT04870177 | Study of AK112 in the Treatment of Advanced Gynecological Tumors | completed | Phase 2 | 53 | AkesoINDUSTRY | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06258564 | The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization | completed | — | 12,000 | Charles University, Czech RepublicOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT04951921 | Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT Therapy | completed | Phase 2 | 6 | Chang Gung Memorial HospitalOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06823817 | Quality Control of Colposcopy Application(QCCA) | completed | — | 10,000 | Peking Union Medical College HospitalOTHER | 0 | Feb 12, 2025 | clinicaltrials |
| NCT01652196 | Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | completed | Phase 2 | 56 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT01814501 | Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | completed | Phase 2 | 16 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT04492007 | Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)(PRISMS) | completed | N/A | 46 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT05496231 | A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age | completed | Phase 1 / Phase 2 | 1,080 | GlaxoSmithKlineINDUSTRY | 8 | Feb 3, 2025 | clinicaltrials |
| NCT04508309 | Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls | completed | Phase 3 | 1,025 | PATHOTHER | 2 | Jan 30, 2025 | clinicaltrials |
| NCT05474404 | Telecytology as a Triage Tool in LMICs | completed | — | 30 | University Hospital, GenevaOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT03483610 | Promoting Cervical Cancer Screening for Emergency Department Patients | completed | N/A | 95 | University of RochesterOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT04275713 | Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC(METOXY-LACC) | completed | Phase 2 | 41 | Oslo University HospitalOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06781073 | Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma | completed | Phase 3 | 118 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT04086771 | Southeast Asian Women's Health Project | completed | N/A | 194 | Ohio State UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT03757299 | Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon(PCCCP) | completed | N/A | 4,473 | Prof. Patrick PetignatOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT06166420 | Home-based Cervical Cancer Screening Project(CASAHO) | completed | N/A | 2,079 | Prof. Patrick PetignatOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT05131581 | Strategies to Improve the Experience of Gynaecological Screening | completed | N/A | 206 | Uppsala UniversityOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT03946358 | Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)(VolATIL) | completed | Phase 2 | 47 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT01658930 | Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer(SHAPE) | completed | N/A | 700 | Canadian Cancer Trials GroupNETWORK | 11 | Dec 17, 2024 | clinicaltrials |
| NCT04587050 | Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV(SHiP) | completed | — | 57 | Imperial College LondonOTHER | 1 | Dec 10, 2024 | clinicaltrials |
| NCT01554397 | Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer | completed | Phase 2 / Phase 3 | 101 | University of California, San DiegoOTHER | 6 | Nov 29, 2024 | clinicaltrials |
| NCT06705309 | Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer | completed | N/A | 128 | Istanbul University - CerrahpasaOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT06700941 | Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment | completed | — | 8,000,000 | Universidad Nacional de ColombiaOTHER | 1 | Nov 22, 2024 | clinicaltrials |
| NCT04274465 | Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia | completed | — | 145 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 14, 2024 | clinicaltrials |
| NCT05862844 | Promise Women Project | completed | N/A | 20 | Mark Dignan, PhDOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT02113878 | Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck | completed | Phase 1 | 23 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT04504669 | First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours | completed | Phase 1 | 60 | AstraZenecaINDUSTRY | 4 | Nov 5, 2024 | clinicaltrials |
| NCT03551028 | HPV DNA Testing Through Mobile Mammography Unit | completed | N/A | 33 | University of VirginiaOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT05227651 | AK104 in Neoadjuvant Treatment of Cervical Cancer | completed | Phase 2 | 14 | AkesoINDUSTRY | 1 | Nov 1, 2024 | clinicaltrials |
| NCT03308591 | Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients | completed | Phase 3 | 774 | Huazhong University of Science and TechnologyOTHER | 1 | Oct 31, 2024 | clinicaltrials |
| NCT01600040 | Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix | completed | N/A | 22 | Massachusetts General HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT02040142 | HIPEC for Peritoneal Carcinomatosis | completed | Phase 2 | 51 | Albert Einstein College of MedicineOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT05959564 | A Chatbot Intervention for Reducing HPV Vaccine Hesitancy | completed | N/A | 456 | University of Maryland, College ParkOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT03721978 | REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) | completed | Phase 3 | 203 | Inovio PharmaceuticalsINDUSTRY | 10 | Oct 17, 2024 | clinicaltrials |
| NCT06644677 | Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis | completed | — | 200 | Peking Union Medical College HospitalOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06313268 | Safety of Effivia®, a Bevacizumab Biosimilar | completed | — | 83 | Laboratorios LiomontINDUSTRY | 1 | Oct 10, 2024 | clinicaltrials |
| NCT03648489 | Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)(DICE) | completed | Phase 2 | 134 | Imperial College LondonOTHER | 2 | Sep 20, 2024 | clinicaltrials |
| NCT05344950 | Connecting Audio and Radio Sensing Systems to Improve Care at Home(AURA) | completed | — | 13 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 6, 2025source: clinicaltrials